LCAT and Hepatic fibrosis: Lu et al. reported that LCAT deficiency exacerbates bone loss in murine models of hepatic osteodystrophy, while LCAT supplementation ameliorates liver fibrosis and enhances hepatic function by facilitating reverse cholesterol transport from bone to liver (Lu et al., 2022).